Navigation Links
Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
Date:6/2/2009

nt of oral therapeutics for the treatment of hepatitis C virus (HCV) and, secondarily, on the development of Racivir(R) for the treatment of human immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for viral replication. We currently have three clinical-stage product candidates: R7128, a nucleoside analog for chronic HCV infections, has initiated a Phase 2b clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV that has completed a Phase 2 clinical trial.

Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
2. Pharmasset Voluntarily Halts Clinical Studies with Clevudine in Hepatitis B Infected Patients
3. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
4. Pharmasset Reports Fiscal Year End 2008 Financial Results
5. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
6. Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications
7. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
8. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
9. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
10. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... FRANCISCO, Calif. , Sept. 2, 2014   Veracyte, ... Bonnie H. Anderson , president and chief executive officer, ... Morgan Stanley Global Healthcare Unplugged Conference 2014 on Monday, September ... York . The live audio webcast and ... http://investor.veracyte.com . Please connect to the website at least ...
(Date:9/2/2014)... , Switzerland , September 2, ... ISO 13485 accreditation, Sophia Genetics has become the first ... use of a Next Generation Sequencing (NGS) bioinformatic ... represents an important step in raising the standards ... brings Sophia Genetics, world-leading Data Driven Medicine platform ...
(Date:9/2/2014)... , Sept. 2, 2014  For over a decade SafeMinds ... link between vaccines and autism. But at least for one ... In a statement , William Thompson , Ph.D. ... linking the MMR vaccine to an increased risk of autism ... the same data suggests that African American males have a ...
Breaking Medicine Technology:Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2CDC vaccine scientist admits wrongdoing. 2CDC vaccine scientist admits wrongdoing. 3
... ... that a new market research report is available in ... A Worldwide Market Review , http://www.reportlinker.com/p0164283/Decubitus-Ulcer-Treatment-Products---A-Worldwide-Market-Review.html ... damage caused by constant pressure of the patient,s bodyweight. ...
... , KING OF PRUSSIA, Pa., Nov. 30 ... Phase I study of CPSI-2364, its orally active, small-molecule inhibitor ... Results of the safety and tolerability dose escalation study in ... clinical testing. , All 30 enrolled subjects completed ...
Cached Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2
(Date:9/2/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief executive officer ... Sioux Falls, S.D. The top executive search firm in ... more than 900 healthcare executives into organizations. , ... and nationally recognized leader in patient-centered care. It is ...
(Date:9/2/2014)... Niagara Falls, New York (PRWEB) September 02, 2014 ... scabies ?” This is the question that millions of ... challenge among health care providers, patients and their families ... lead to misdiagnosis due to its distinct similarities to ... atopic dermatitis, impetigo, bed bug bites, eczema, varicella and ...
(Date:9/2/2014)... September 02, 2014 QueenBeeTickets.com , home ... is now stocking James Taylor concert tickets for the singer’s ... U.S. cities from November 1 to the 19th. , James ... again on the 4th of the month. General onsales to ... are all set to obtain seats for one of his ...
(Date:9/2/2014)... September 02, 2014 ZAMST, a leader ... endorsement deal with professional baseball star Nolan Arenado ... best young baseball players, Arenado will be working with ... specific product category. , Arenado was selected by ... #59 overall. In 2013, Arenado was awarded the Gold ...
(Date:9/2/2014)... At the 50th Annual Mr. Olympia Fitness ... exhibitor at the Las Vegas Convention Center South Hall, ... Booth #374 Sept 19th and 20th 10am-5PM. , ... exercise, diet and supplementation. They pride themselves on creating ... for all Prosupps customers to reach their personal health ...
Breaking Medicine News(10 mins):Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 4Health News:James Taylor Presale Tickets for 10 November Concerts On Sale Today From Trusted Provider QueenBeeTickets.com 2Health News:Gold Glove Baseball Star Nolan Arenado Signs With Zamst 2Health News:Prosupps, One of the Fastest Growing Supplement Companies, Celebrates a Success Milestone with Exhibiting at the 50th Annual 2014 Mr. Olympia’s Fitness & Performance Expo 2
... Journal has just come out. In it,s 23rd year it helps new ... progress. It is both a keepsake, and a lifesaver in an emergency. ... inception. A diaper bag must. , ... Fountain Valley, CA (PRWEB) January ...
... Robert L. Peck discusses connections between the mind and body, hormone ... aware of the effects of hormones and how many of the ... ... Lebanon, CT (PRWEB) January 21, 2009 -- ,Controlling Your Hormones, ...
... CINCINNATI After identifying an apparent population of cancer ... herpes virus to block tumor formation in mice by ... 21 by PLoS (Public Library of Science) One ... Center adds to a growing body of evidence suggesting ...
... came into effect, granting children 12 years and older ... the right to access condoms. But current policies ... give out condomspolicies that two researchers, writing in this ... health of the country,s youth. , Juliana Han (Harvard ...
... , ... (PRWEB) January 20, 2009 -- It has come ... confusion as to the intentions of its iPhone application previously for ... to its attention-grabbing name, and the unfortunate media confusion and common ...
... health and exercise programs have positive outcomes despite having ... exercise they do outside of school, say Cochrane Researchers ... physical activity programs in schools. , The research shows ... and reduced the time spent watching television. Programs also ...
Cached Medicine News:Health News:Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms 2Health News:Pocket Reference Journals Releases Latest Edition of "All About Me" Leading Children's Immunization Journal for New Moms 3Health News:Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life 2Health News:Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life 3Health News:Engineered virus targets and kills apparent cancer stem cells in neuroblastoma 2Health News:Engineered virus targets and kills apparent cancer stem cells in neuroblastoma 3Health News:South African policy on adolescents' rights to access condoms is causing confusion 2Health News:Teen Torture iPhone App Discontinued Due to Public Alarm 2Health News:Teen Torture iPhone App Discontinued Due to Public Alarm 3Health News:School-based physical activity: Has benefits even if it doesn't help lose weight 2
Enzyme Immunoassay of von Willebrand Factor Antigenby ELISA Method, 96 tests....
Enzyme Immunoassay of Factor IX Antigen by ELISA Method, 96 tests....
Enzyme Immunoassay of Platelet Factor 4 Antigen by ELISA Method, 96 tests....
HbA1c / HbCalibrator...
Medicine Products: